"Phentolamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
Descriptor ID |
D010646
|
MeSH Number(s) |
D03.383.129.308.754
|
Concept/Terms |
Phentolamine Mesylate- Phentolamine Mesylate
- Mesylate, Phentolamine
- Phentolamine Methanesulfonate
- Methanesulfonate, Phentolamine
- Phentolamine Mesilate
- Mesilate, Phentolamine
|
Below are MeSH descriptors whose meaning is more general than "Phentolamine".
Below are MeSH descriptors whose meaning is more specific than "Phentolamine".
This graph shows the total number of publications written about "Phentolamine" by people in this website by year, and whether "Phentolamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Phentolamine" by people in Profiles.
-
Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses. Am J Hypertens. 1989 Jun; 2(6 Pt 1):428-34.
-
Differential effects of phentolamine on the responsiveness of aortic and femoral smooth muscle from normotensive and DOCA/NaCl hypertensive rats. Artery. 1986; 13(6):325-39.
-
Phentolamine and rat aortic smooth muscle responsiveness to potassium chloride, isoproterenol and norepinephrine. Pharmacology. 1985; 31(2):67-71.
-
Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980 May; 65(5):949-57.
-
Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979 Jul; 16(1):34-46.
-
Evidence for an intrarenal beta receptor in control of renin release. Am J Physiol. 1976 Feb; 230(2):410-8.
-
Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia. Diabetes. 1971 Sep; 20(9):607-14.
-
Inhibition of insulin secretion by catecholamines in pheochromocytoma. Ann Intern Med. 1969 Aug; 71(2):251-6.